Please login to the form below

Not currently logged in
Email:
Password:

Dominic Moorhead joins Ferring Pharmaceuticals

He takes up executive VP and chief financial officer role

Dominic MoorheadSwitzerland-based Ferring Pharmaceuticals has appointed Dominic Moorhead as its new executive vice president and chief financial officer.

Following a three-month transition period, Moorhead will assume full responsibility for the Finance, Corporate Information Systems and International Audit functions.

With over 30 years experience in the life sciences industry, Moorhead has held a number of senior roles such as strategic advisor to executives and investors in biotech, global financial controller for Takeda Pharmaceuticals, and CFO of the international business following the acquisition of Nycomed.

Prior to this, he served Hoffman- La Roche (Roche) where he was CFO of its pharma division for nine years.

Michel Pettigrew, president of the executive board and chief operating officer of Ferring, said: “His extensive experience and perspectives in finance, business and strategic development in the pharmaceutical sector make him a great fit for Ferring as we continue on our strong growth path.”

Moorhead succeeds Peter Wilden who will still continue to represent Ferring on a number of additional boards.

5th April 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics